Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Former, current Taisun executives detained in tainted oil probe
07/25/2026 09:17 PM - Politics
Opposition rallies in Taipei over tainted cooking oil scandal
07/25/2026 08:48 PM - Culture
Foreign applicants for Taiwanese language test hit 5-year high
07/25/2026 06:57 PM - Business
CPC to raise domestic gasoline, diesel prices next week
07/25/2026 05:55 PM - Politics
KMT rallies candidates ahead of 2026 local elections
07/25/2026 04:45 PM